MANZO PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | -.--% |
| 21/05 | Manzo Pharmaceuticals, Inc. announced that it expects to receive $0.0005 million in funding | CI |
| 2015 | Manzo Pharmaceuticals Inc. Announces New Product Somnaid Release | CI |
Volumes
marketsDaily volume
200
Estimated daily volume
200
Record volume 1
138 320 100
Record volume 2
136 135 300
Record volume 3
135 640 800
Capital turnover ratio
0.00
Basic data
Capitalization (USD)
1 099
Net sales (USD)
3 069 747
Number of employees
12
Sales / Employee (USD)
255 812
Free-Float
0 %
Free-Float capitalization (USD)
0
Highs and lows
3 years
0.00
0.00
5 years
0.000.00
10 years
0.000.02
Indicators
RSI 9 days
0.00
RSI 14 days
0.00
Sector Comparison - Specialty & Advanced Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 1.1K | ||
| +1.12% | -0.75% | +15.54% | +2.30% | 78.51B | ||
| +2.87% | +3.41% | +12.05% | -0.91% | 9B | ||
| +0.58% | +7.34% | +58.17% | +117.57% | 4.96B | ||
| +1.55% | +2.28% | -14.94% | +16.19% | 4.84B | ||
| -1.43% | -1.71% | -.--% | +21.82% | 3.72B | ||
| +0.84% | +6.48% | +21.94% | -0.69% | 2.48B | ||
| -0.60% | -0.55% | -26.63% | -32.91% | 2.19B | ||
| +0.62% | +0.97% | +16.75% | -6.23% | 2.12B | ||
| -1.13% | -4.76% | -37.97% | -48.91% | 1.94B | ||
| -.--% | -.--% | - | - | 1.64B | ||
| +2.07% | -1.42% | -6.29% | -18.17% | 1.49B | ||
| +3.46% | +3.61% | +0.77% | -2.73% | 1.23B | ||
| +2.06% | +2.24% | -16.68% | -29.83% | 1.07B | ||
| +0.10% | +81.83% | +63.81% | +126.55% | 1.06B | ||
| -2.24% | -1.92% | +32.75% | +29.66% | 845M | ||
| Average | +0.62% | +5.97% | +8.52% | +12.41% | ||
| Weighted average by Cap. | +1.08% | +0.88% | +13.62% | +7.19% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -.--% | ||
| 2023 | -99.00% | ||
| 2022 | -88.89% | ||
| 2021 | +89,900.00% | ||
| 2020 | -99.00% | ||
| 2019 | +9,900.00% | ||
| 2018 | -99.67% | ||
| 2017 | +200.00% | ||
| 2016 | -83.33% | ||
| 2015 | -50.00% | ||
| 2014 | +20.00% | ||
| 2013 | -.--% | ||
| 2012 | -75.00% | ||
| 2011 | -95.29% | ||
| 2010 | +750.00% | ||
| 2009 | +233.33% | ||
| 2008 | -92.68% | ||
| 2007 | -79.50% | ||
| 2006 | -33.33% | ||
| 2005 | -40.00% | ||
| 2004 | -44.44% | ||
| 2003 | -76.32% | ||
| 1999 | +46.15% | ||
| 1998 | -99.42% | ||
| 1997 | -96.00% | ||
| 1996 | -64.00% | ||
| 1995 | +38.89% | ||
| 1994 | -51.35% | ||
| 1993 | +48.00% | ||
| 1992 | -32.43% |
- Stock Market
- Equities
- MNZO Stock
- Quotes Manzo Pharmaceuticals, Inc.
